Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
14.10
+0.32 (2.32%)
At close: Oct 8, 2025, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT

Benitec Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2016 - 2020
370307657933
Upgrade
Market Cap Growth
294.59%369.05%881.17%-29.60%-71.60%294.06%
Upgrade
Enterprise Value
271205521222
Upgrade
Last Close Price
13.7811.706.994.0519.7272.25
Upgrade
PS Ratio
---88.98129.85565.78
Upgrade
PB Ratio
3.723.161.3933.043.291.67
Upgrade
P/TBV Ratio
3.793.161.3933.043.291.67
Upgrade
EV/Sales Ratio
---9.9423.51367.04
Upgrade
Debt / Equity Ratio
0.010.010.012.770.280.01
Upgrade
Asset Turnover
---0.010.010.00
Upgrade
Quick Ratio
54.2654.2610.380.641.6114.46
Upgrade
Current Ratio
54.6754.6710.490.941.9015.05
Upgrade
Return on Equity (ROE)
-52.46%-52.46%-91.68%-1268.61%-159.08%-91.79%
Upgrade
Return on Assets (ROA)
-34.39%-34.39%-49.60%-228.53%-81.59%-51.55%
Upgrade
Return on Capital (ROIC)
-35.84%-35.84%-58.21%-535.50%-93.32%-55.06%
Upgrade
Earnings Yield
-10.30%-12.35%-33.22%-293.13%-192.09%-41.59%
Upgrade
FCF Yield
-6.41%-7.69%-29.91%-269.92%-167.86%-39.10%
Upgrade
Buyback Yield / Dilution
-97.17%-97.17%-1225.17%-188.30%-90.24%-320.63%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q